• Advancing Translational Apoptosis Research with Robust TUNEL

  2026-06-10

  This article provides translational researchers with a mechanistic exploration of apoptosis detection, strategic guidance for experimental design, and actionable insights on leveraging the One-step TUNEL Cy3 Apoptosis Detection Kit. By integrating recent advances in targeted cancer therapy, such as the discovery of nitroaromatic nannocystins in colorectal cancer, and benchmarking against real-world workflows, we illuminate how precise DNA fragmentation assays can drive both basic and clinical research forward.

• Redefining Mouse Genotyping for Translational Immunology

  2026-06-10

  This thought-leadership article explores how streamlined genotyping, enabled by the Direct Mouse Genotyping Kit Plus, is accelerating translational research into macrophage plasticity, liver metastasis, and immunomodulation. Bridging recent lineage-tracing advances with strategic guidance, it highlights experimental best practices, protocol nuances, and the kit’s role in empowering reproducible, high-resolution genetic studies critical for next-generation immunotherapies.

• Tropifexor (LJN452): A Potent FXR Modulator for Barrier Rese

  2026-06-09

  Tropifexor (LJN452) is a synthetic, high-affinity FXR agonist used in metabolic and intestinal barrier research. It offers nanomolar potency and robust gene modulation, validated in both in vitro and in vivo models. This article details its mechanism, best-use parameters, and common research misconceptions.

• Cy5 TSA Fluorescence System Kit: Sensitive Detection for IHC

  2026-06-09

  The Cy5 TSA Fluorescence System Kit transforms immunohistochemistry and in situ hybridization by enabling ultra-sensitive, cost-effective detection of elusive targets. Leveraging horseradish peroxidase catalyzed tyramide deposition, it empowers researchers to confidently visualize low-abundance biomarkers while conserving valuable primary antibodies.

• Decoding Colonic Injury: DSS Models & Epithelial Repair Circ

  2026-06-08

  A thought-leadership article for translational researchers integrating mechanistic insights into epithelial repair with strategic guidance for leveraging Dextran sulfate sodium salt (MW 35000-45000) in preclinical inflammatory bowel disease models. The piece contextualizes the GPR35-KLF5 axis in mucosal healing, offers protocol optimization, and delineates the translational impact of robust DSS-based workflows.

• Azathramycin A: Macrolide Antibiotic Workflows in TB Researc

  2026-06-08

  Azathramycin A offers researchers precise ribosomal inhibition for Mycobacterium tuberculosis models, enabling targeted studies of protein synthesis inhibition and resistance mechanisms. This article delivers actionable protocol parameters, troubleshooting strategies, and translational insights for leveraging Azathramycin A in antibacterial and resistance research.

• AG-120 (Ivosidenib): Precision Workflows for Mutant IDH1 AML

  2026-06-07

  AG-120 (Ivosidenib) enables robust, reproducible reduction of the oncometabolite 2-hydroxyglutarate and restoration of myeloid differentiation in AML models harboring mutant IDH1. This guide translates recent metabolic rewiring insights into optimized experimental protocols, advanced troubleshooting, and actionable strategies for overcoming resistance mechanisms.

• Dimethyloxalylglycine (DMOG): Protocols and Technical Guidan

  2026-06-06

  Dimethyloxalylglycine (DMOG) is a cell-permeable PHD inhibitor designed for precise stabilization of hypoxia-inducible factors, enabling controlled studies of hypoxia signaling and inflammation in research models. It is not suitable for diagnostic or therapeutic applications, and strict protocol adherence is required for reproducible results.

• Intraperitoneal Programming of CAR Macrophages with mRNA-LNP

  2026-06-05

  This study introduces an mRNA lipid nanoparticle system for intraperitoneal programming of chimeric antigen receptor macrophages (CAR-Ms), enabling robust anti-tumor immunity in peritoneal metastasis. The approach systematically optimizes CAR design for macrophage activation and demonstrates synergy with checkpoint blockade, offering a novel strategy for solid tumor immunotherapy.

• HDAC Inhibitors Potentiate Oncolytic HSV Therapy in Malignan

  2026-06-05

  Kawamura et al. demonstrate that histone deacetylase inhibitors, including Trichostatin A (TSA), significantly enhance the efficacy of oncolytic herpes simplex virus (oHSV) therapy against malignant meningioma models. Their work provides evidence for a synergistic epigenetic-virotherapy approach, with implications for otherwise treatment-refractory brain tumors.

• NS1-Induced DNMT1 Degradation Shapes HBoV1 Replication and R

  2026-06-04

  This study demonstrates that human bocavirus 1 (HBoV1) manipulates host DNA methylation through NS1-mediated DNMT1 degradation, directly impacting viral DNA replication and RNA processing. These findings reveal a new epigenetic regulatory mechanism in parvoviral infection, providing a foundation for future antiviral strategy development.

• CD44-Driven Metabolic Rewiring in IDH-Mutant Leukemia

  2026-06-04

  This study uncovers a crucial dependency in IDH-mutant acute myeloid leukemia: the upregulation of CD44, which drives metabolic rewiring to sustain NADPH generation and oncometabolite production. The findings highlight the therapeutic potential of co-targeting CD44 and mutant IDH1, with implications for overcoming resistance and optimizing myeloid differentiation strategies.

• Leptin (116-130), amide, mouse: Applied Protocols & Assay Ad

  2026-06-03

  Leptin (116-130), amide, mouse unlocks precise modeling of energy homeostasis and immune-metabolic crosstalk for obesity and diabetes research. This guide delivers protocol-driven insights, troubleshooting, and advanced applications for leveraging this adipocyte-derived hormone fragment in translational workflows.

• Deferoxamine Mesylate: Iron-Chelating Agent for Oxidative St

  2026-06-03

  Deferoxamine mesylate stands out as a versatile iron-chelating agent, enabling precise control of iron-mediated oxidative stress, hypoxia signaling, and tumor growth inhibition in preclinical models. This article details actionable workflows, advanced applications, and troubleshooting strategies that empower researchers to maximize assay reliability and biological insight.

• Sulfamonomethoxine in Applied Research: Protocols and Optimi

  2026-06-02

  Sulfamonomethoxine (SMM) stands out as a research-grade veterinary antibiotic for both infection control and environmental fate studies. This article translates cutting-edge findings into actionable workflows, troubleshooting strategies, and comparative insights for scientists in veterinary, aquaculture, and environmental domains.

15821 records 1/1055 page Next 12345 下5页 Last page